(Q44611988)

English

Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy'.

scientific article published in October 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14535875%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy' (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14535875%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Helicobacter pylori

1 reference

based on heuristic

inferred from title

Helicobacter pylori infectious disease

1 reference

based on heuristic

inferred from title

Angelo Andriulli

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14535875%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14535875%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

author name string

F Perri

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14535875%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

V Festa

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14535875%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

F Barberani

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14535875%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

A Pilotto

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14535875%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

language of work or name

0 references

publication date

1 October 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14535875%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14535875%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14535875%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14535875%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

815-820

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14535875%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01755.X

21 January 2018

Ranitidine bismuth citrate-based triple therapies after failure of the standard 'Maastricht triple therapy': a promising alternative to the quadruple therapy?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01755.X

21 January 2018

Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01755.X

21 January 2018

Levofloxacin based regimens for the eradication of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01755.X

21 January 2018

A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01755.X

21 January 2018

A citric acid solution is an optimal test drink in the 13C-urea breath test for the diagnosis of Helicobacter pylori infection.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01755.X

21 January 2018

Predictors of failure of Helicobacter pylori eradication with the standard 'Maastricht triple therapy'.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01755.X

21 January 2018

Helicobacter pylori strains and histologically-related lesions affect the outcome of triple eradication therapy: a study from southern Italy.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01755.X

21 January 2018

Risk factors for failure of Helicobacter pylori therapy--results of an individual data analysis of 2751 patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01755.X

21 January 2018

Triple therapy with clarithromycin, omeprazole, and amoxicillin for eradication of Helicobacter pylori in duodenal ulcer patients in Asia and Africa

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01755.X

21 January 2018

Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01755.X

21 January 2018

Increased primary resistance to recommended antibiotics negatively affects Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01755.X

21 January 2018

Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01755.X

21 January 2018

Treatment of antibiotic-resistant Helicobacter pylori.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01755.X

21 January 2018

Rifabutin-based triple therapy after failure of Helicobacter pylori eradication treatment: preliminary experience.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01755.X

21 January 2018

Randomized study of two "rescue" therapies for Helicobacter pylori-infected patients after failure of standard triple therapies

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01755.X

21 January 2018

Rifabutin-based Helicobacter pylori eradication 'rescue therapy'.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01755.X

21 January 2018

'Rescue' therapy with rifabutin after multiple Helicobacter pylori treatment failures

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01755.X

21 January 2018

Detection of rifabutin resistance and association of rpoB mutations with resistance to four rifamycin derivatives in Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01755.X

21 January 2018

Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01755.X

21 January 2018

A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE Study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01755.X

21 January 2018

Review article: the pharmacology of rabeprazole

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01755.X

21 January 2018

Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01755.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44611988&oldid=2203880598"